Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
2
×
detroit blog main
detroit top stories
europe blog main
europe top stories
gilead sciences
immunomedics
2
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle genetics
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
accent therapeutics
aducanumab
allergan aesthetics
What
bio
roundup
acquisitions
activity
approvals
biggest
biogen
build
buy
ceo
clamped
company’s
covid
daniel
debut
delays
developing
drug
dyne’s
economic
fast
fda
gilead
including
ipo
isn’t
lot
medicines
microbiome
moves
new
openly
oric’s
o’day
pipeline
sciences
scores
seagen
showing
spoken
Language
unset
Current search:
immunomedics
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
